XOMA Royalty (XOMA) Depreciation and Depletion (2014 - 2017)
XOMA Royalty (XOMA) reported Depreciation and Depletion of $58000.0 for Q3 2017, down 68.65% on a YoY basis from $185000.0 in Q3 2016, and down 68.65% sequentially from $185000.0 in Q3 2016.
XOMA Royalty (XOMA) Depreciation and Depletion (2014 - 2017) Analysis & Trends
XOMA Royalty (XOMA) has 4 years of Depreciation and Depletion data on file, last reported at $58000.0 in Q3 2017.
- For the quarter ending Q3 2017, Depreciation and Depletion fell 68.65% year-over-year to $58000.0; the trailing twelve-month figure through Sep 2017 stood at $661000.0 (down 19.0% YoY), and the FY2015 full-year result was $1.5 million, down 17.46% from the prior year.
- Depreciation and Depletion eased to $58000.0 in Q3 2017, from $185000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $458000.0 in Q4 2014 to a low of $58000.0 in Q3 2017.
- A 4-year average of $294555.6 and a median of $215000.0 in 2016 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion slumped 53.06% in 2016 and slumped 68.65% in 2017, its largest moves.
- Tracing XOMA's Depreciation and Depletion over 4 years: stood at $458000.0 in 2014, then plunged by 53.49% to $213000.0 in 2015, then dropped by 13.15% to $185000.0 in 2016, then tumbled by 68.65% to $58000.0 in 2017.
- Business Quant data shows XOMA's Depreciation and Depletion at $58000.0 in Q3 2017, $185000.0 in Q3 2016, and $203000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 58,000.00 |
| Sep 30, 2017 | 58,000.00 |
| Sep 30, 2016 | 185,000.00 |
| Sep 30, 2016 | 185,000.00 |
| Jun 30, 2016 | 203,000.00 |
| Jun 30, 2016 | 203,000.00 |
| Mar 31, 2016 | 215,000.00 |
| Mar 31, 2016 | 215,000.00 |
| Dec 31, 2015 | 213,000.00 |
| Dec 31, 2015 | 213,000.00 |
| Sep 30, 2015 | 417,000.00 |
| Sep 30, 2015 | 417,000.00 |
| Jun 30, 2015 | 444,000.00 |
| Jun 30, 2015 | 444,000.00 |
| Mar 31, 2015 | 458,000.00 |
| Mar 31, 2015 | 458,000.00 |
| Dec 31, 2014 | 458,000.00 |
| Dec 31, 2014 | 458,000.00 |